Navigation Links
Criterion Gel/Plate Blot System

ProductsCriterion Gel/Plate Blot System
Company Bio-Rad Lab Equipment
Item Criterion Gel/Plate Blot System
Features Inquire
Description Includes: Criterion cell for running Criterion precast gels and Criterion blotter with plate electrodes.
A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-use of the Mini Trans-Blot system.
Info Bio-Rad Lab Equipment
Customer Service: 510-741-5790
Web site: http://www.bio-rad.com/

Related medicine products :

1. Criterion™ II Urine Analyzer
2. Criterion Gel Holder Cassettes 2
3. Criterion Blotter w/ Plate Electrodes
4. Criterion Blotter w/ Wire Electrodes
5. Criterion Gel/Wire Blot System
6. Criterion Dodeca Cell
7. Silicone Oil Cannula System - 20 Gauge
8. Silicone Oil Cannula System - 19 Gauge
9. SuperVu Galilean System
10. KOWA nonmyd 7 / VK-2 Digital Imaging System
11. KOWA nonmyd a-D / VK-2 Digital Imaging System
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:
(Date:12/6/2009)... Cambridge have discovered that the loss of a key segment ... the first study to show that this kind of genetic ... Nature . , The study, led by Dr Sadaf ... from the Wellcome Trust Sanger Institute, looked at 300 children ... genome looking for types of mutation known as copy number ...
(Date:12/6/2009)... DNA in virus , , SUNDAY, Dec. 6 (HealthDay News) -- ... found in a tiger that lived thousands or millions of ... virus took on a bit of a tiger,s genetic material, ... the virus to this day. That tiger, in fact, may ... virus that ultimately led to its infection of humans. , ...
(Date:12/6/2009)... 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... the pivotal Phase 2b 003-A1 study, known as ... in heavily pre-treated relapsed and refractory multiple myeloma ... ASH/ASCO Joint Symposium at the 51st annual meeting ... New Orleans. Enrollment in this trial is complete ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Blood clotting, or ... bleeding when a blood vessel is injured. Sometimes, ... without an obvious injury or do not dissolve ... presented today at the 51st Annual Meeting of ... practice of using the anticoagulants aspirin and heparin ...
(Date:12/6/2009)... Internet Sleep Disorders information and Treatment site ... sleep problems with herbal or natural sleep aids ... ,insomnia remedies for a good cause. The submissions ... Natural Sleep Aids ,Encyclopedia, by YOU, to be ... The site will donate 100% of the proceeds ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... claim against City of New York and New York City Police ... ... 2008 -- http://thesandersfirm.com/attorney.asp?attorneyid=14 [Marc Grossman], senior partner of leading ... & Grossman, P.C. in Bronx, New York, today announced that his ...
... Calif., Aug. 27 Patient Safety,Technologies, Inc. (PST) (OTC ... $2.325 million in equity financing in a first closing ... enhancing sales and,marketing at its SurgiCount Medical subsidiary. Investors ... shares of the,Company,s common stock at a price of ...
... 27 Replidyne, Inc.,(Nasdaq: RDYN ) today ... employee headcount by approximately 80% to 5 employees ... September 2008 and October,2008. As a result of ... REP3123, its investigational agent for the,treatment of Clostridium ...
... medical students will gain access to innovative medical, ... the first satellite, radio channel created for medical ... ReachMD XM 157 announced today a new,strategic ... the nation,s oldest and largest, independent,association for physicians-in-training., ...
... Nashville, TN Injury prevention experts have long known ... wear seat belts while driving. Now, researchers from the ... lack of seat belt use by teen passengers may ... ever direct comparison of the differences between driver and ...
... insulin-resistant proteins, study says , , WEDNESDAY, Aug. 27 (HealthDay News) ... those in lean people, a new study shows. , ... group of researchers from the Temple University School of Medicine ... and six obese people. , They found significant differences in ...
Other Medicine News:Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Patient Safety Technologies Closes on $2.325 Million in Equity Financing 2Health News:Replidyne Announces Restructuring of Operations 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 3Health News:Teens making poor choices when it comes to riding in vehicles 2
(Date:12/4/2009)... The U.S. Food and Drug Administration (FDA) today approved ... the treatment of schizophrenia and manic or mixed episodes ... years old. ,, The updated Zyprexa label states ... for weight gain and hyperlipidemia in adolescents compared to ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
(Date:12/4/2009)... Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... enrolled in the company,s Phase II-b, dose escalation, clinical ... traumatic brain injury (TBI). Oxycyte is the Company,s perfluorocarbon ... invaluable importance in improving the outcome of patients with ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Constipation May Lead to Other Problems 50223 1Constipation May Lead to Other Problems 50223 2Constipation May Lead to Other Problems 50223 3Jackson International Launches New Website in Collaboration with Medicaview International 50220 1Jackson International Launches New Website in Collaboration with Medicaview International 50220 2Jackson International Launches New Website in Collaboration with Medicaview International 50220 3Jackson International Launches New Website in Collaboration with Medicaview International 50220 4The science of hammering 9025 1